Ignite Creation Date:
2024-05-06 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 12:47 PM
Study NCT ID:
NCT03556020
Status:
TERMINATED
Last Update Posted:
2022-08-23
First Post:
2018-06-01
Brief Title:
Phase 2 Study to Assess Safety Tolerability and Efficacy of Once Weekly SC Pemziviptadil PB1046 in Subjects With Symptomatic PAH
Sponsor:
Organization:
PhaseBio Pharmaceuticals Inc